Junshi Biosciences seeks raising up to $414M in HK IPO

Source: Dukascopy Bank SA
Shanghai Junshi Biosciences, China's biotech company, is hoping to attract up to $414M in its planned initial public offering in Hong Kong by selling 158.9M of its shares at the price range of $2.48-$2.61.
Back to articles

Actual Topics

Mon, 10 Dec 2018 20:22:41 GMT

ASG lifts its bid to $11.50 per share to acquire Mitek

ASG Technologies Group, owned by the buyout group Elliott Management, raised its offer to acquire Mitek Systems to $11.50 for a share from the previous stock price of $10, as the company put all efforts to clinch a takeover deal with the fintech provider to banks.

Mon, 10 Dec 2018 19:32:02 GMT

Elliott, Siris take Travelport private in $4.4B deal

The buyout companies Elliott Management and Siris Capital Group are set to take Travelport Worldwide private in a $4.4B deal, after Elliott's eight month-long efforts to acquire the travel software firm alone.

Subscribe to "Fundamental Analysis" feed

Subscribe
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.